Cargando…
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Distinguishing malignant cells from non-neoplastic ones is a major challenge in triple-negative breast cancer (TNBC) treatment. Here, we developed a complementary targeting strategy that uses precisely matched, multivalent ligand-receptor interactions to recognize and target TNBC tumors at the prima...
Autores principales: | Guo, Peng, Yang, Jiang, Liu, Daxing, Huang, Lan, Fell, Gillian, Huang, Jing, Moses, Marsha A., Auguste, Debra T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426465/ https://www.ncbi.nlm.nih.gov/pubmed/30906868 http://dx.doi.org/10.1126/sciadv.aav5010 |
Ejemplares similares
-
ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
por: Guo, Peng, et al.
Publicado: (2016) -
Peptide density targets and impedes triple negative breast cancer metastasis
por: Liu, Daxing, et al.
Publicado: (2018) -
Nanoparticle elasticity directs tumor uptake
por: Guo, Peng, et al.
Publicado: (2018) -
Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer
por: Si, Yingnan, et al.
Publicado: (2021) -
GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)